Osteoporosis Treatment Market Size, Share & Industry Analysis, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator (SERMs), RANK ligand (RANKL) Inhibitor, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Others), and Regional Forecast, 2019-2026

Region : Global | Format: PDF | Report ID: FBI101034

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Pipeline Analysis
2. Key Industry Developments such as Mergers, Acquisitions, and Collaborations
3. New Product Launches
4. Key Industry Trends
Global Osteoporosis Treatment Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Bisphosphonate
  2. Hormone Replacement Therapy
  3. Selective Estrogen Receptor Modulator (SERMs)
  4. RANK ligand (RANKL) Inhibitor
  5. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Stores
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Osteoporosis Treatment Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Bisphosphonate
  2. Hormone Replacement Therapy
  3. Selective Estrogen Receptor Modulator (SERMs)
  4. RANK ligand (RANKL) Inhibitor
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Stores
  3. Online Pharmacies
5. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Osteoporosis Treatment Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Bisphosphonate
  2. Hormone Replacement Therapy
  3. Selective Estrogen Receptor Modulator (SERMs)
  4. RANK ligand (RANKL) Inhibitor
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Stores
  3. Online Pharmacies
5. Market Analysis – By Country/ sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Osteoporosis Treatment Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Bisphosphonate
  2. Hormone Replacement Therapy
  3. Selective Estrogen Receptor Modulator (SERMs)
  4. RANK ligand (RANKL) Inhibitor
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Stores
  3. Online Pharmacies
5. Market Analysis – By Country/ sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Osteoporosis Treatment Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Bisphosphonate
  2. Hormone Replacement Therapy
  3. Selective Estrogen Receptor Modulator (SERMs)
  4. RANK ligand (RANKL) Inhibitor
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Stores
  3. Online Pharmacies
5. Market Analysis – By Country/ sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Osteoporosis Treatment Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Drug Class
  1. Bisphosphonate
  2. Hormone Replacement Therapy
  3. Selective Estrogen Receptor Modulator (SERMs)
  4. RANK ligand (RANKL) Inhibitor
  5. Others
3. Market Analysis – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Stores
  3. Online Pharmacies
5. Market Analysis – By Country/ sub-region
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2017)
3. Competition Dashboard
4. Comparative Analysis – Major Players
5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. AbbVie Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  2. Eli Lilly and Company
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  3. Amgen Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  4. F. Hoffmann-La Roche Ltd
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  5. Novartis AG
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  6. Sanofi
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  7. Pfizer Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  8. Merck & Co., Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  9. GlaxoSmithKline plc
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
Strategic Recommendations

Read Less

List of Figures

Figure 1: Global Osteoporosis Treatment Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2: Global Osteoporosis Treatment Market Value Share (%), by Drug Class, 2018 & 2026

Figure 3: Global Osteoporosis Treatment Market Forecast (US$ Mn), by Bisphosphonate, 2015-2026

Figure 4: Global Osteoporosis Treatment Market Forecast (US$ Mn), by Hormone Replacement Therapy, 2015-2026

Figure 5: Global Osteoporosis Treatment Market Forecast (US$ Mn), by Selective Estrogen Receptor Modulator (SERMs), 2015-2026

Figure 6: Global Osteoporosis Treatment Market Forecast (US$ Mn), by RANK ligand (RANKL) Inhibitor, 2015-2026

Figure 7: Global Osteoporosis Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 8: Global Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2018 & 2026

Figure 9: Global Osteoporosis Treatment Market Forecast (US$ Mn), by Oral, 2015-2026

Figure 10: Global Osteoporosis Treatment Market Forecast (US$ Mn), by Parenteral, 2015-2026

Figure 11: Global Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 12: Global Osteoporosis Treatment Market Forecast (US$ Mn), by Hospitals Pharmacies, 2015-2026

Figure 13: Global Osteoporosis Treatment Market Forecast (US$ Mn), by Retail Pharmacies & Stores, 2015-2026

Figure 14: Global Osteoporosis Treatment Market Forecast (US$ Mn), by Online Pharmacies, 2015-2026

Figure 15: Global Osteoporosis Treatment Market Value (US$ Mn), by Region, 2018 & 2026

Figure 16: North America Osteoporosis Treatment Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 17: North America Osteoporosis Treatment Market Value Share (%), by Drug Class, 2018

Figure 18: North America Osteoporosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 19: North America Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 20: North America Osteoporosis Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 21: North America Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 22: North America Osteoporosis Treatment Market Value (US$ Mn), By Country, 2018 & 2026

Figure 23: North America Osteoporosis Treatment Market Value Share (%), By Country, 2018

Figure 24: Europe Osteoporosis Treatment Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 25: Europe Osteoporosis Treatment Market Value Share (%), by Drug Class, 2018

Figure 26: Europe Osteoporosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 27: Europe Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 28: Europe Osteoporosis Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 29: Europe Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 30: Europe Osteoporosis Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 31: Europe Osteoporosis Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 32: Asia Pacific Osteoporosis Treatment Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 33: Asia Pacific Osteoporosis Treatment Market Value Share (%), by Drug Class, 2018

Figure 34: Asia Pacific Osteoporosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 35: Asia Pacific Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 36: Asia Pacific Osteoporosis Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 37: Asia Pacific Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 38: Asia Pacific Osteoporosis Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 39: Asia Pacific Osteoporosis Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 40: Latin America Osteoporosis Treatment Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 41: Latin America Osteoporosis Treatment Market Value Share (%), by Drug Class, 2018

Figure 42: Latin America Osteoporosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 43: Latin America Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 44: Latin America Osteoporosis Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 45: Latin America Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 46: Latin America Osteoporosis Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 47: Latin America Osteoporosis Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 48: Middle East & Africa Osteoporosis Treatment Market Value (US$ Mn), by Drug Class, 2018 & 2026

Figure 49: Middle East & Africa Osteoporosis Treatment Market Value Share (%), by Drug Class, 2018

Figure 50: Middle East & Africa Osteoporosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 51: Middle East & Africa Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 52: Middle East & Africa Osteoporosis Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 53: Middle East & Africa Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 54: Middle East & Africa Osteoporosis Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 55: Middle East & Africa Osteoporosis Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 56: Global Osteoporosis Treatment Market Share (%), By Company, 2018

List of Tables

Table 1: Global Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Drug Class, 2015–2026

Table 2: Global Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015–2026

Table 3: Global Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 4: Global Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5: North America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 6: North America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 7: North America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 8: North America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9: Europe Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 10: Europe Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 11: Europe Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 12: Europe Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13: Asia Pacific Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 14: Asia Pacific Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 15: Asia Pacific Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16: Asia Pacific Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17: Latin America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 18: Latin America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 19: Latin America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20: Latin America Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21: Middle East & Africa Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Drug Class, 2015-2026

Table 22: Middle East & Africa Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 23: Middle East & Africa Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 24: Middle East & Africa Osteoporosis Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

PUBLISHED ON:Apr, 2020
BASE YEAR:2018
HISTORICAL DATA: 2015-2017
NO OF PAGES: 135

Healthcare Clients

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry

Get in Touch with Us

+1 424 253 0390 (US)
+44 2071 939123 (UK)
+91 744 740 1245 (APAC)
[email protected]

Features		Type of License
Features		Single User	Multi User	Enterprise User
Pricing		US$ 4850	US$ 5850	US$ 7850
Number of Users Who can Access the Report		1 user only	2 to 6 users	Unlimited access within the organization
Free Customization		20 hours	40 hours	60 hours
Duration of Free Analyst Support		3 months post purchase	6 months post purchase	12 months post purchase
Direct access to the Analyst Team (through calls/email)
Deliverable Format	PDF
	Excel
	Power Point
Discount on Your Next Purchase (applicable to 1 report only for the same license type)		No Discount	15%	25%
Permission to Print the Report